Ifenprodil Tartrate is primarily used in research settings to study its effects on the central nervous system. It acts as a selective antagonist of the NMDA receptor, specifically targeting the NR2B subunit, which makes it valuable in exploring mechanisms related to neuroprotection and neurological disorders. Researchers utilize it to investigate conditions such as stroke, Alzheimer's disease, and chronic pain, as it helps in understanding the role of glutamate signaling in these pathologies. Additionally, it has been studied for its potential in mitigating excitotoxicity, a process that leads to neuronal damage. Its application in preclinical studies provides insights into developing therapeutic strategies for neurodegenerative diseases and brain injuries.